Skip to content

Clinical trials

Observational Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Observational Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20034
20052
20063
20074
20084
20097
20102
20112
20127
20136
20145
20151
20168
20176
20187
20197
202010
20217
20228
20238
20248
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Unknown status22
Recruiting21
Not yet recruiting8
Terminated6
Active, not recruiting5
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital8
Stanford University6
Onkovis GmbH4
Bayer3
Maastricht University Medical Center3
National Institute of Neurological Disorders and Stroke (NINDS)3
Eisai Co., Ltd.2
Integrated Diagnostics2
Jinling Hospital, China2
Latin American Cooperative Oncology Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma131
Neoplasms25
Carcinoma, Non-Small-Cell Lung24
Lung Neoplasms18
Adenocarcinoma17
Carcinoma, Renal Cell14
Breast Neoplasms10
Carcinoma, Hepatocellular10
Carcinoma, Squamous Cell9
Colorectal Neoplasms8

Trials

Showing 51 to 75 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.